The impacts of biomarkers on precision
Pfizer’s Precision Medicine Pipeline and Technology Portfolio
Legal and Liability Implications of Pharmacogenomics for Physicians and Pharmacists
New Genomic and Epigenetic Profiling Assays Are Blueprints for the Development of Comprehensive Biomarker Testing for Cancer
Integration of gene expression profiling and artificial intelligence into personalized diagnostics for improved patient care
DNA Synthesis – An Integral Force in the Founding and Future of Precision Medicine
Putting PGx into Practice
CE and the SCIEX BioPhase 8800 in Precision Medicine
Advancing Spatial Biology through Highly Multiplexed Protein Imaging: The Orion™ Platform
The essentials for a powerful clinical decision support software with embedded PGx: Evidence driven platform integrated into an EHR
Part 2 – Surveillance of Wastewater and Prevention Platform (SWAPP): A Case Study of Digital Public Health and SARS-CoV-2
Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malignancies
Novel Physiological Vital Sign for Behavioral Health
Colon Cancer – A Review
Research at Cedars Sinai – CANCER
